These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31583799)

  • 21. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
    Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
    Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
    Sun B; Deng C; Meng F; Zhang J; Zhong Z
    Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyacrylic acid modified upconversion nanoparticles for simultaneous pH-triggered drug delivery and release imaging.
    Jia X; Yin J; He D; He X; Wang K; Chen M; Li Y
    J Biomed Nanotechnol; 2013 Dec; 9(12):2063-72. PubMed ID: 24266261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y; Xing H; Song F; Yang Y; Qiu Z; Lu X; Liu Q; Ren S; Chen X; Li N
    J Pharm Sci; 2016 Sep; 105(9):2949-2958. PubMed ID: 27209461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy.
    Wang C; Cheng L; Liu Z
    Biomaterials; 2011 Feb; 32(4):1110-20. PubMed ID: 20965564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting thyroid cancer with acid-triggered release of doxorubicin from silicon dioxide nanoparticles.
    Li S; Zhang D; Sheng S; Sun H
    Int J Nanomedicine; 2017; 12():5993-6003. PubMed ID: 28860762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
    Mou Q; Ma Y; Zhu X; Yan D
    J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial Targeted Doxorubicin-Triphenylphosphonium Delivered by Hyaluronic Acid Modified and pH Responsive Nanocarriers to Breast Tumor: in Vitro and in Vivo Studies.
    Liu HN; Guo NN; Wang TT; Guo WW; Lin MT; Huang-Fu MY; Vakili MR; Xu WH; Chen JJ; Wei QC; Han M; Lavasanifar A; Gao JQ
    Mol Pharm; 2018 Mar; 15(3):882-891. PubMed ID: 29357260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH-responsive Virus-like Nanoparticles with Enhanced Tumour-targeting Ligands for Cancer Drug Delivery.
    Biabanikhankahdani R; Alitheen NBM; Ho KL; Tan WS
    Sci Rep; 2016 Nov; 6():37891. PubMed ID: 27883070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A targeted drug delivery system based on folic acid-functionalized upconversion luminescent nanoparticles.
    Liang X; Fan J; Zhao Y; Cheng M; Wang X; Jin R; Sun T
    J Biomater Appl; 2017 Apr; 31(9):1247-1256. PubMed ID: 28350205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M; Badiee A; Golmohammadzadeh S; Sadri K; Akhtari J; Mellat M; Nikpoor AR; Jaafari MR
    Int J Pharm; 2016 Sep; 511(1):236-244. PubMed ID: 27363937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diselenide linkage containing triblock copolymer nanoparticles based on Bi(methoxyl poly(ethylene glycol))-poly(ε-carprolactone): Selective intracellular drug delivery in cancer cells.
    Hailemeskel BZ; Hsu WH; Addisu KD; Andrgie AT; Chou HY; Lai JY; Tsai HC
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109803. PubMed ID: 31349440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surface-Modified Nanoerythrocyte Loading DOX for Targeted Liver Cancer Chemotherapy.
    Wang Y; Chen X; He D; Zhou Y; Qin L
    Mol Pharm; 2018 Dec; 15(12):5728-5740. PubMed ID: 30359027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin.
    Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N
    Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphological evolution of upconversion nanoparticles and their biomedical signal generation.
    Rafique R; Baek SH; Park CY; Chang SJ; Gul AR; Ha S; Nguyen TP; Oh H; Ham S; Arshad M; Lee H; Park TJ
    Sci Rep; 2018 Nov; 8(1):17101. PubMed ID: 30459423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
    Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA Microcapsule for Photo-Triggered Drug Release Systems.
    Kamiya Y; Yamada Y; Muro T; Matsuura K; Asanuma H
    ChemMedChem; 2017 Dec; 12(24):2016-2021. PubMed ID: 28948693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design of pH/reduction dual-responsive nanoparticles as drug delivery system for DOX: Modulating controlled release behavior with bimodal drug-loading.
    Liu P; Zhang R; Pei M
    Colloids Surf B Biointerfaces; 2017 Dec; 160():455-461. PubMed ID: 28985607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.